Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes
Hidenori Ando(Institute of Biomedical Science), Tatsuhiro Ishida(Institute of Biomedical Science)
Cited by 17
Related Papers
Potential Efficacy of Proteasome Inhibitor, Delanzomib, for the Treatment of Renal Fibrosis
|Biological and Pharmaceutical Bulletin|2023|3